This Startup Used AI To Design A Drug In 21 Days

Hong Kong-based Insilico Medicine published research Monday showing that its deep learning system could identify potential treatments for fibrosis. That system, called generative tensorial reinforcement learning, or GENTRL for short, was able to find six promising treatments in just 21 days, one of which showed promising results in an experiment involving mice. The research has been published in Nature Biotechnology, and the code for the model has been made available on Github.

Read more https://www.forbes.com/sites/alexknapp/2019/09/02/this-startup-used-ai-to-design-a-drug-in-21-days/#7a498c932594